Mr. John D McDermott This is Me

Education

 View all 54 references Web References

1. 1. investor.endologix.com

   investor.endologix.com/managem - [Cached]

   Published on: 6/18/2008   Last Visited: 6/18/2008

   John McDermottPresident and Chief Executive Officer
   
   John McDermott, 47, joined Endologix in May 2008 as President and Chief Executive Officer.He has nearly 20 years of executive management, sales, marketing and finance experience in the vascular device industry.From 2002 to 2007 he served as President of Bard Peripheral Vascular, a division of C.R. Bard, Inc. that earned several corporate awards for global sales growth, business development, income growth and sales from new products during his tenure.He previously was President of Global Sales for C.R. Bard's vascular surgery and endovascular businesses with responsibilities for managing a worldwide direct sales force with more than 200 representatives.Prior to that he served for four years as President of C.R. Bard division IMPRA, Inc., where he was responsible for global operations, including sales, marketing, research and development, manufacturing and finance.From 1990 to 1996 he was Chief Financial Officer and later Vice President and Chief Operating Officer of IMPRA, Inc., prior to its acquisition by C.R. Bard.He has been an active leader within the vascular community and was formerly on the board of directors of the International Society of Endovascular Specialists (ISES) and the Vascular Disease Foundation.
   ...
   John McDermottPresident and Chief Executive Officer
   
   John McDermott, 47, joined Endologix in May 2008 as President and Chief Executive Officer.He has nearly 20 years of executive management, sales, marketing and finance experience in the vascular device industry.From 2002 to 2007 he served as President of Bard Peripheral Vascular, a division of C.R. Bard, Inc. that earned several corporate awards for global sales growth, business development, income growth and sales from new products during his tenure.He previously was President of Global Sales for C.R. Bard's vascular surgery and endovascular businesses with responsibilities for managing a worldwide direct sales force with more than 200 representatives.Prior to that he served for four years as President of C.R. Bard division IMPRA, Inc., where he was responsible for global operations, including sales, marketing, research and development, manufacturing and finance.From 1990 to 1996 he was Chief Financial Officer and later Vice President and Chief Operating Officer of IMPRA, Inc., prior to its acquisition by C.R. Bard.He has been an active leader within the vascular community and was formerly on the board of directors of the International Society of Endovascular Specialists (ISES) and the Vascular Disease Foundation.

2. 2. clearstation.etrade.com

   clearstation.etrade.com/cgi-bi - [Cached]

   Published on: 5/12/2008   Last Visited: 5/14/2008

   Endologix Names John McDermott President and CEOClearStation : News Articles : ELGX
   ...
   IRVINE, Calif., May 12, 2008 (BUSINESS WIRE) -- Endologix, Inc. (ELGX, Trade), developer and manufacturer of the Powerlink(R) System for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today announced that John McDermott (age 47) has been named President, Chief Executive Officer and a director of the Company, effective May 12, 2008.
   ...
   Mr. McDermott brings to Endologix nearly 20 years of executive management, sales, marketing and finance experience in the vascular device industry.From 2002 to 2007 he served as President of Bard Peripheral Vascular, a division of C.R. Bard, Inc., that earned several corporate awards for global sales growth, business development, income growth and sales from new products during his tenure.
   
   Mr. McDermott previously was President of Global Sales for C.R. Bard's vascular surgery and endovascular businesses.
   ...
   "The board of directors selected John to serve as President and CEO following an extensive nationwide search, and we are truly fortunate to find a professional with his proven leadership skills.We are confident that John has the ideal professional background to take our Company to the next level.I have known John for nearly 10 years and have the utmost respect for his integrity and knowledge of the vascular surgery market," said Endologix Chairman Franklin D. Brown.
   ...
   Commenting on his appointment, Mr. McDermott said, "The opportunity at Endologix is tremendous as we work to leverage a premier endovascular technology in a growing market.I look forward to working with my new colleagues and the Endologix board to support growing sales of the Powerlink System, while continuing to commercialize additional high-value products based on the Powerlink platform and other technologies at Endologix."
   
   Mr. McCormick said, "I have known John personally for many years and am impressed with his outstanding leadership qualities, experience and record of success in the peripheral vascular arena.
   ...
   I look forward to continuing my association with Endologix as a board member, and to assisting John during a brief period of transition."
   
   Mr. McDermott holds an M.B.A. in marketing and international business from Western International University in Phoenix, Arizona, and a B.S. in Finance from Arizona State University.He has been an active leader within the vascular community and was formerly on the board of directors of the International Society of Endovascular Specialists (ISES) and the Vascular Disease Foundation.
   ...
   John McDermott, President and CEO, 949-595-7200 www.endologix.com or

3. 3. Angiotech

   www.angio.com/?seeknamed=direc - [Cached]

   Published on: 4/21/2004   Last Visited: 4/21/2004

   John McDermott, MBA
   
   President, BARD Peripheral Vascular
   
   John McDermott joined Angiotech's Board of Directors in September 1999. Mr. McDermott is the President of Bard Peripheral Vascular, a Division of C.R. Bard, Inc.